Decision to discontinue IFX

CT Chinatsu Takai
SI Satoshi Ito
DK Daisuke Kobayashi
TN Tetsuya Nemoto
HL Hyunho Lee
AA Asami Abe
HO Hiroshi Otani
KN Kiyoshi Nakazono
AM Akira Murasawa
HI Hajime Ishikawa
request Request a Protocol
ask Ask a question
Favorite

The decision to discontinue IFX was made by consultation and agreement between the patients and physicians. No precise criteria were established, but when patients maintained CR for more than two years, we proposed the discontinuation of IFX. If patients wished to discontinue treatment before two years' remission due to financial reasons, then we discontinued the therapy.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A